Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Sanadent 1 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.2% 2.5% 3.6% 3.2% 2.3% 1.6% 11.4% 11.4%   Credit score (0-100)   85 64 54 57 64 74 20 20   Credit rating   A BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   134.3 0.0 0.0 0.0 0.1 9.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,195 5,440 441 -70.5 77.4 -14.1 0.0 0.0   EBITDA   1,284 2,183 1,655 -354 -399 -764 0.0 0.0   EBIT   735 1,894 1,548 -392 -415 -776 0.0 0.0   Pre-tax profit (PTP)   823.1 2,019.0 1,969.9 777.7 1,340.3 1,136.8 0.0 0.0   Net earnings   650.0 1,580.8 1,547.0 606.5 1,130.8 813.9 0.0 0.0   Pre-tax profit without non-rec. items   823 2,019 1,970 778 1,340 1,137 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   855 450 299 42.2 26.2 14.6 0.0 0.0   Shareholders equity total   3,018 899 2,146 2,027 3,158 3,972 3,722 3,722   Interest-bearing liabilities   810 1,412 974 1,387 1,429 452 0.0 0.0   Balance sheet total (assets)   4,839 3,847 4,035 3,705 5,019 4,799 3,722 3,722   Net Debt   802 1,402 970 1,364 1,415 351 -3,722 -3,722     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,195 5,440 441 -70.5 77.4 -14.1 0.0 0.0   Gross profit growth   0.0% 4.7% -91.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Employees   0 10 1 1 1 1 0 0   Employee growth %   0.0% 0.0% -90.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,839 3,847 4,035 3,705 5,019 4,799 3,722 3,722   Balance sheet change%   0.0% -20.5% 4.9% -8.2% 35.5% -4.4% -22.4% 0.0%   Added value   734.6 1,893.6 1,548.4 -391.8 -414.7 -775.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   306 -694 -257 -294 -32 -23 -15 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.1% 34.8% 350.9% 556.1% -535.6% 5,495.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.0% 47.6% 50.3% 20.1% 31.7% 23.2% 0.0% 0.0%   ROI %   22.1% 65.8% 66.5% 22.1% 34.5% 25.2% 0.0% 0.0%   ROE %   21.5% 80.7% 101.6% 29.1% 43.6% 22.8% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   63.7% 24.9% 53.2% 54.7% 62.9% 82.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   62.5% 64.2% 58.6% -385.2% -354.8% -45.9% 0.0% 0.0%   Gearing %   26.8% 157.0% 45.4% 68.4% 45.3% 11.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.8% 4.3% 1.1% 0.0% 3.0% 0.2% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   2.2 1.1 2.7 2.2 1.9 4.7 0.0 0.0   Current Ratio   2.2 1.1 2.7 2.2 1.9 4.7 0.0 0.0   Cash and cash equivalent   7.3 9.4 3.8 23.5 14.5 101.3 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,116.4 325.9 2,345.1 1,959.7 1,755.0 2,931.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 189 1,548 -392 -415 -776 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 218 1,655 -354 -399 -764 0 0   EBIT / employee   0 189 1,548 -392 -415 -776 0 0   Net earnings / employee   0 158 1,547 606 1,131 814 0 0